Category: news

CMP Pharma announced that the US Food and Drug Administration (FDA) has granted final approval of the company’s New Drug Application (NDA) for CaroSpir® (Spironolactone Oral Suspension, 25 mg/5mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone.
“CaroSpir® provides a stable, ready to use and consistent liquid treatment option for adult patients, including those who have difficulty swallowing, or who cannot swallow tablets,” said Gerald Sakowski, CEO at CMP Pharma, Inc. “Up until now, these patients have been prescribed a pharmacy compounded liquid form of spironolactone. The dosing inconsistencies of compounded liquids have long been a persistent challenge for physicians.”
CaroSpir® will be introduced early in the fourth quarter of 2017. For more information, contact CMP Pharma at 252-753-7111, or visit CaroSpir.com
About CaroSpir®
CaroSpir® (spironolactone oral suspension) is indicated for treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema and to reduce the need for hospitalization for heart failure, and is usually administered in conjunction with other therapies. CaroSpir® is also indicated for use as an add-on therapy for the treatment of hypertension, to lower blood pressure in adult patients who are not adequately controlled on other agents, and as part of comprehensive cardiovascular risk management. Lastly, CaroSpir® is indicated for the management of edema in adult cirrhotic patients when edema is not responsive to fluid and sodium restriction.
CaroSpir® is contraindicated for patients with the following conditions: hyperkalemia, Addison’s disease, and concomitant use of eplerenone.
About CMP Pharma, Inc.
CMP Pharma is a specialty pharmaceutical company that addresses critical needs for niche markets by developing and manufacturing a portfolio of high value liquid and semi-solid pharmaceutical products. CMP Pharma combines decades of experience in pharmaceutical development and manufacturing to provide medicines to fill the unmet medical needs of many patients.
Additional Important Safety Information
Contraindications
CAROSPIR is contraindicated for patients with the following conditions:
Hyperkalemia
Addison’s disease
Concomitant use of eplerenone
Warnings and Precautions / Adverse Reactions
CAROSPIR may cause the following conditions.
Hyperkalemia
Hypotension and Worsening Renal Function
Electrolyte and Metabolic Abnormalities
Gynecomastia
Impaired neurological function/coma in patients with hepatic impairment, cirrhosis and ascites
The most common adverse reaction (incidence > 5%) with CAROSPIR treatment is the increased occurrence of gynecomastia in men.

GAFFEY Healthcare, a leading provider of revenue cycle technology and outsourced services, finds talent from within the organization and promotes Elrene Clinkscales and Suzanne Dusak to Vice President.
GAFFEY Healthcare, a leading provider of revenue cycle technology and outsourced services, announces the internal promotion of Elrene Clinkscales to Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice President of Operations – Claims & Remittance Management, reporting to Derek Morkel, chief executive officer (CEO).
Elrene has been with company since Oct 2014 and previously was the Director of Implementation & Client Services. Suzanne has a long history with GAFFEY, being with the company since June 2003. Her previous position was the Director of Operations, Claims & Remittance Management.
“It is truly exciting for me to be able to find the talent from within our organization to lead this company on its quest to be the best in our industry,” commented Derek Morkel. “I have worked very closely with both Elrene and Suzanne and have been impressed not only with their knowledge of our company and products, but their unwavering attention to customer service and incremental improvement.”
GAFFEY Healthcare provides revenue cycle automation technology and services that enable health care organizations to accelerate cash flow, improve productivity and increase profitability with short-term and demonstrable ROI. From automated claims statusing, patient eligibility and payment verification to billing and claims management to third-party collections, their software relies upon cloud-based, state-of-the art workflow supported by a business intelligence platform. GAFFEY’s systems are in use at more than 200 healthcare systems and physician practices across the U.S.

Fueled by rapid growth, Minnesota-based medical technology company expands facilities.
Minnetronix, Inc., a leading medical technology company, today announced that it has completed a 22,000 square foot facilities expansion. Driven by strong and consistent growth, this investment initiative increases production capacity by 50% and accommodates the company’s expanding team, which has nearly doubled over the past two years. The company has also added a dedicated New Product Commercialization space designed to enhance quality and accelerate time to market.
Minnetronix also announced today that Jeremy Maniak has been promoted to President of the company. Maniak joined Minnetronix in 2010 and has served as COO since 2013. In his new position, Maniak will maintain operational leadership while increasing his focus on strategic direction for the company. Minnetronix co-founder Rich Nazarian, who has served as its President since the company’s founding in 1996, will continue as CEO and Chairman of the Board.
Minnetronix has established a niche designing, developing and manufacturing products for hundreds of medical device companies across the globe. The company now leverages more than two decades of growth and expertise to develop its own proprietary technologies to augment existing projects, increase the pace of commercialization and provide solutions in underserved markets.
“Jeremy’s appointment and the investments we are making in our operations are strong reflections of Minnetronix’ positive trajectory,” said Nazarian. “I’m excited that our team and enhanced facilities are really well-positioned to respond to the changing med-tech landscape and the increasing demand for our services and technologies.”
Anthony Millar, Vice President of Operations for Minnetronix said, “Our Operations team is focused on superior execution as well as unparalleled quality and compliance. This investment ensures that as Minnetronix grows, our team will continue to have the processes and facilities to produce world-class medical technologies for customers and patients.”

Partnering with 4R Technologies as an additional staffing option for GAFFEY customers, GAFFEY Healthcare demonstrates a core commitment to deliver the right people at the right time, performing the right tasks in a cost effective solution.
GAFFEY Healthcare, a leading provider of revenue cycle automation technology and outsourced services, announces a partnership with 4R Technologies in Capetown, South Africa. This provides an additional staffing option for GAFFEY customers and further demonstrates a core commitment to delivering the right people at the right time and performing the right tasks in a cost effective solution.
South Africa is increasingly being selected for offshoring due to a shared culture, high quality work products, staff with or pursuing advanced degrees, and low cost of living. While there are a growing number of partners available, GAFFEY selected 4R Technologies due to a mutual affinity to use technology as a driving force in improving people and processes.
“Macro-level financial challenges such as the payment model shift to value-based care, chronic care management, and high patient insurance churn rate are just a few examples that require significant oversight and resources to ensure proper billing and collections,” confirmed Derek Morkel, GAFFEY Chief Executive Officer. “Our relationship with 4R Technologies allows more flexibility for our customers. They will enjoy working with world class professionals, while benefiting from an average of 40-50% cost savings from talent in the United States. Our partnership with 4R Technologies provides assurance we are prepared for the impending market changes.”
GAFFEY Healthcare provides revenue cycle automation technology and services that enable health care organizations to accelerate cash flow, improve productivity and increase profitability with short-term and demonstrable ROI. From automated claims statusing, patient eligibility and payment verification to billing and claims management to third-party collections, their software relies upon cloud-based, state-of-the art workflow supported by a business intelligence platform. GAFFEY’s systems are in use at more than 200 healthcare systems and physician practices across the U.S.

When Anthony Millar joined Minnetronix in August of 2016, he brought more than 15 years of medical device manufacturing experience to the operations team. Anthony has used his expertise in new product development, materials management and supply chain along with his extensive experience in lean and Six Sigma methodologies to bring significant enhancements to Minnetronix manufacturing operations. We sat down with Anthony to learn more about his goals, his team and what inspires him.
Over the past year, Minnetronix has made strategic investments in Manufacturing Operations. What were your goals for this initiative?
The medical device world is in a time of transition. We continue to see a growing number of mergers and acquisitions that are changing our customer base. In Operations, we have to be ready to meet the needs of an even broader spectrum of customers. The investments we are making in our people, processes and facilities are intensely focused on delivering superior execution, unparalleled quality and compliance on every project and for every customer.
One of the most significant enhancements to Operations is the New Product Commercialization team and space. What is the team’s primary objective and what benefit does this provide to our customers?
This investment has allowed us to look holistically at our processes and to improve the way we move products from development into commercial manufacturing. Creating a New Product Commercialization (NPC) team and space dedicated to development and tech transfer projects is central to our goal of providing faster pathways to commercialization and continuously improving quality. Our team includes highly skilled electronics assemblers who support product builds from early stage prototype through post DVT pilot builds; process development engineers who accelerate selection, procurement, and qualification of the best equipment, tooling, fixtures, and raw materials; and quality engineers who tailor quality system requirements to meet the unique needs of each customer. Ultimately, the NPC team’s early exposure to projects in development and enhanced communication will benefit both our customers and the patients they serve.
What motivates your team?
We have a talented team with broad and deep experience. What both links and drives us is an innate desire to help people. We wake up every morning knowing that the work we do is making a positive difference in the world. How great is that?
What is one quality you think is essential in your position?
Adaptability. At Minnetronix, we work with customers from small startups to billion dollar multi-nationals. We pride ourselves in being able to meet, and often exceed, customer expectations. This is especially important given the inevitability of changing circumstances associated with our diverse customer base.
Where do you look for inspiration?
My Dad was a successful Operations executive until his retirement in 2016. His story is the classic American dream. When I was born, he was working as a 3rd shift production operator in the coil coating industry. I can remember my mom telling my brothers and me that we had to keep quiet while in the house during the day so my Dad could sleep. By the time I graduated from college, he was the president of a $200M+ division of that same company. Watching him operate over the years, I learned the value of a strong work ethic and techniques for building and developing great teams. When I run into an issue, I can always count on my Dad to have an applicable story to share and to help me devise a go forward strategy.

Chemical Computing Group (CCG) and the American Chemical Society’s (ACS) Division of Medicinal Chemistry (MEDI) congratulate the winners of the CCG Excellence Awards for the Fall 2017 ACS National Meeting in Washington, DC.
The award winners’ research will be recognized at the MEDI Division Poster Session on Sunday, August 20th, 2017. Each winner will receive an award certificate, a one-year MOE (Molecular Operating Environment) software license for the winners’ research group, as well as financial support to cover their travel costs to Washington.
The winners are:

• Saloni Patel, Duquesne University, group of Patrick Flaherty
• Britanny Morgan, Duke University, group of Amanda Hargrove

About CCG Research Excellence Awards
The Chemical Computing Group (CCG) Excellence Awards were created to recognize and promote young scientists who use computational chemistry to further their scientific research. For more information about the CCG Excellence Awards, please visit: chemcomp.com/research-academic.htm
About Chemical Computing Group
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG continues to provide state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG’s software platform is the Molecular Operating Environment (MOE) which is used by computational chemists, medicinal chemists and biologists in the major pharmaceutical and biotechnology companies throughout the world. CCG has a very strong reputation for collaborative scientific support, maintaining support offices in both Europe and North America. Founded in 1994, CCG is headquartered in Montreal, Canada. For more information visit: chemcomp.com

Chemical Computing Group (CCG) and the American Chemical Society’s (ACS) Division of Computers in Chemistry (COMP) congratulate the winners of the CCG Excellence Awards for the Fall 2017 ACS National Meeting in Washington, DC.
The award winners’ research will be recognized at the COMP Division Poster Session on Tuesday, August 22nd, 2017. Each winner will receive an award certificate, a one-year MOE (Molecular Operating Environment) software license for the winners’ research group, as well as financial support to cover their travel costs to Washington.
The winners are:

• Hoshin Kim, North Caroline State University, group of Yaroslava G. Yingling
• Zhongyue Yang, University of California, group of Kendall N. Houk
• Evgenii Fetisov, University of Minnesota, group of J. Iljia Siepmann
• Daniel Nascimento, Florida State University, group of A. Eugene DePrince III
• David Williams-Young, University of Washington, group of Xiaosong Li

About CCG Excellence Awards
The Chemical Computing Group (CCG) Excellence Awards were created to recognize and promote young scientists who use computational chemistry to further their scientific research. For more information about the CCG Excellence Awards, please visit: chemcomp.com/research-academic.htm
About Chemical Computing Group
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG continues to provide state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG’s software platform is the Molecular Operating Environment (MOE) which is used by computational chemists, medicinal chemists and biologists in the major pharmaceutical and biotechnology companies throughout the world. CCG has a very strong reputation for collaborative scientific support, maintaining support offices in both Europe and North America. Founded in 1994, CCG is headquartered in Montreal, Canada. For more information visit: chemcomp.com

Altaris Capital Partners, LLC (“Altaris”) is pleased to announce that it has exited its investment in Quantum Health, Inc. (“Quantum Health”) as part of a recapitalization transaction with Great Hill Partners.
Founded in 1999 and headquartered in Columbus, OH, Quantum is a leading provider of consumer navigation and care coordination to large self-insured employers. Quantum Health and Altaris were advised on this transaction by William Blair & Company, LLC.
About Quantum Health
Quantum Health is an award-winning consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Quantum Health’s model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Quantum Health has earned numerous awards and honors, including being named a Fastest-Growing Privately Held Company for the past nine years by Inc. 5000; one of the 50 Fastest-Growing Women-Owned/Led Companies for the past nine years by the Women Presidents’ Organization; a Best Place to Work for the past ten years by Columbus Business First; and a Great Place to Work® Best Small & Medium Workplaces by FORTUNE Magazine and Entrepreneur Magazine. Learn more at www.quantum-health.com.

New York, NY: Altaris Capital Partners, LLC announces investment in Chemical Computing Group.
Chemical Computing Group (“CCG”), headquartered in Montreal, Canada, is a provider of molecular design software for the pharmaceutical, chemical and material industries. CCG’s software platform, the Molecular Operating Environment (“MOE”), streamlines drug discovery and chemical engineering processes by allowing researchers to visualize and predict molecular properties and interactions. MOE is an established market leader with more than 20 years of product development and scientific publications. www.chemcomp.com

Senior Helpers®, the nation’s premier provider of in-home senior care, today announced it has been selected to receive the 2017 Caregiver Friendly® Award by Today’s Caregiver, the first national magazine for all family and professional caregivers, and caregiver.com. The Caregiver Friendly® Awards are designed to celebrate products, services, books and media created with the needs of caregivers in mind.
“Being a family caregiver is an extremely challenging job—balancing work, life and caring for a loved one is no easy feat,” said Chris Buitron, chief marketing officer, Senior Helpers. “We understand that family caregivers face emotional, physical and financial hardships and we aim to relieve at least some of the burden associated with caring for an elderly loved one. It is an honor to be recognized for something we at Senior Helpers are so passionate about.”
Founded in 2001 with a vision to help seniors who wish to remain in their homes – despite age-related illnesses and mobility challenges – Senior Helpers serves elderly individuals and their families around the world. Senior Helpers differentiates itself with its proprietary, specialized programs that have been developed in collaboration with leading medical experts. The company was the first provider in the industry to offer specialized care services for individuals with Alzheimer’s, dementia and Parkinson’s disease.
“The average caregiver is responsible for over $40,000 in health related expenditures each year, in either personal or directed funds,” said Gary Barg, Today’s Caregiver magazine’s Editor-in-Chief, “This award is designed to help family caregivers recognize and reward those organizations who will care for them in as committed a manner as they care for their loved ones.”
Award winners will also be announced in the July/August 2017 issue of Today’s Caregiver and on the magazine’s website, caregiver.com.
For more information about Senior Helpers, visit seniorhelpers.com.
About Senior Helpers
Senior Helpers is a premier in-home senior care provider with 311 franchised businesses operating across the globe. Founded in 2001 with a vision to help seniors who wish to remain in their homes despite age-related illnesses and mobility challenges, Senior Helpers has now cared for tens of thousands of seniors with a pledge to provide “care and comfort at a moment’s notice.” Senior Helpers offers a wide range of personal care and companion services, including trained Alzheimer’s, dementia and Parkinson’s care, to assist seniors who wish to live independently. Learn more by visiting seniorhelpers.com.
About The Caregiver Friendly Awards
Caregiver Friendly® Awards are presented by Today’s Caregiver magazine to celebrate outstanding books, media, products and services designed with the best interest of the family caregiver in mind. Today’s Caregiver magazine, launched in 1995, is published by Caregiver Media Group, which also produces the Fearless Caregiver Conferences, www.caregiver.com and The Fearless Caregiver book which teaches caregivers how to become their loved one’s fearless advocates within the healthcare system.